Burning Rock Biotech (BNR) Enterprise Value (2020 - 2025)
Historic Enterprise Value for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to -$66.0 million.
- Burning Rock Biotech's Enterprise Value rose 702.11% to -$66.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.0 million, marking a year-over-year increase of 702.11%. This contributed to the annual value of -$71.9 million for FY2024, which is 1709.4% up from last year.
- As of Q3 2025, Burning Rock Biotech's Enterprise Value stood at -$66.0 million, which was up 702.11% from -$63.5 million recorded in Q2 2025.
- In the past 5 years, Burning Rock Biotech's Enterprise Value ranged from a high of -$63.5 million in Q2 2025 and a low of -$322.5 million during Q1 2021
- In the last 5 years, Burning Rock Biotech's Enterprise Value had a median value of -$101.1 million in 2023 and averaged -$137.5 million.
- As far as peak fluctuations go, Burning Rock Biotech's Enterprise Value surged by 4525.57% in 2022, and later soared by 702.11% in 2025.
- Over the past 5 years, Burning Rock Biotech's Enterprise Value (Quarter) stood at -$195.9 million in 2021, then surged by 31.5% to -$134.2 million in 2022, then surged by 35.41% to -$86.7 million in 2023, then grew by 17.44% to -$71.5 million in 2024, then grew by 7.72% to -$66.0 million in 2025.
- Its Enterprise Value stands at -$66.0 million for Q3 2025, versus -$63.5 million for Q2 2025 and -$68.9 million for Q1 2025.